| Mon, Nov 23, 2009 |
| • |
Cleveland BioLabs Opens Enrollment of Second Safety Study for CBLB502
Marketwire (Mon, Nov 23)
|
| Wed, Nov 18, 2009 |
| • |
Cleveland BioLabs Publishes New Insights Into Mechanism of Action of Curaxins, Extending Their Clinical Potential
Marketwire (Wed, Nov 18)
|
| • |
CLEVELAND BIOLABS INC Financials
EDGAR Online Financials (Wed, Nov 18)
|
| Thu, Nov 12, 2009 |
| • |
CLEVELAND BIOLABS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Nov 12)
|
| Mon, Nov 2, 2009 |
| • |
Cleveland BioLabs to Present at Merriman 6th Annual Investor Summit
Marketwire (Mon, Nov 2)
|
| Tue, Oct 20, 2009 |
| • |
Cleveland BioLabs to Host Roundtable on Protectan CBLB502 for Acute Radiation Syndrome
Marketwire (Tue, Oct 20)
|
| Mon, Oct 19, 2009 |
| • |
Cleveland BioLabs to Present at 8th Annual BIO Investor Forum
Marketwire (Mon, Oct 19)
|
| Tue, Oct 6, 2009 |
| • |
Department of Defense Increases Ongoing Contract With Cleveland BioLabs for Developmental Studies Related to Protectan CBLB502
Marketwire (Tue, Oct 6)
|
| Mon, Oct 5, 2009 |
| • |
Rodman & Renshaw Initiates Analyst Coverage of Cleveland BioLabs
Marketwire (Mon, Oct 5)
|
| Wed, Sep 30, 2009 |
| • |
Cleveland BioLabs keeps cashing in
at bizjournals.com (Wed, Sep 30)
|
| • |
Armed Forces Radiobiology Research Institute and Cleveland BioLabs Awarded Grant From Department of Defense to Study Radioprotective Effects of Protectan CBLB600 Series
Marketwire (Wed, Sep 30)
|
| Tue, Sep 29, 2009 |
| • |
More cancer funds for Cleveland BioLabs
at bizjournals.com (Tue, Sep 29)
|
| • |
Coverage initiated on Cleveland Biolabs by Rodman & Renshaw
Briefing.com (Tue, Sep 29)
|
| • |
Cleveland BioLabs Awarded $5.3 Million Grand Opportunities Grant From National Institutes of Health for Protectan CBLB502 Research in Mitigation of Radiation Damage of GI Tract
Marketwire (Tue, Sep 29)
|
| Thu, Sep 24, 2009 |
| • |
Gov't adds to Cleveland BioLabs contract
at bizjournals.com (Thu, Sep 24)
|
| • |
Cleveland BioLabs Receives $2.3 Million Addition to $13.3 Million Contract With Biomedical Advanced Research and Development Authority (BARDA) to Develop Radiation Countermeasure Protectan CBLB502
Marketwire (Thu, Sep 24)
|
| Tue, Sep 22, 2009 |
| • |
NIH ups ClevelandBioLabs research
at bizjournals.com (Tue, Sep 22)
|
| • |
National Institute of Allergy and Infectious Diseases Awards Cleveland BioLabs Additional Grant for Protectan CBLB502 Research in Mitigation of Radiation Damage
Marketwire (Tue, Sep 22)
|
| Mon, Sep 21, 2009 |
| • |
Cleveland BioLabs to Present at Maxim Group Growth Conference
Marketwire (Mon, Sep 21)
|
| Tue, Sep 15, 2009 |
| • |
Oncogene Testing Patents Key In Evaluating Stock Picks In Medical Research Sector According To Industry Expert
Wall Street Transcript (Tue, Sep 15)
|
| Older Headlines |
|
|
|
|
Help
Headlines
